Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Interaction study of rocephin (ceftriaxone) with calcium-containing products

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: NAKAI, Yuka (Department of pharmacy, Bell Land General Hospital, Sakai,osaka, Japan)
  • Co-author(s): Tokuyama, Emi (School of Pharmaceutical Sciences, Mukogawa Women's University, Japan)
    Ishizaka, Toshihiko (Department of Pharmacy, Izumi Municipal Hospital, Japan)
    Yoshida, Miyako (School of Pharmaceutical Sciences, Mukogawa Women's University, Japan)
    Uchida, Takahiro (School of Pharmaceutical Sciences, Mukogawa Women's University, Japan)
  • Abstract:

    In 2007, FDA published the Alert which highlights important revisions to the CONTRAINDICATIONS, WARNINGS, and DOSAGE and ADMINISTRATION sections of the full prescribing information for Rocephin. This information focused on the interaction of ceftriaxone with calcium-containing products based on reports of fatal cases in neonates. Although there..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses